<p>InfuSystem Holdings, Inc. (NYSE:INFU - 获取免费报告) 收到了五位分析师的平均推荐评级为 “买入”，MarketBeat 报道。一位投资分析师给予该股票持有评级，两位给予买入评级，另外两位则对该公司给予强烈买入评级。在过去一年中，发布报告的经纪人对该股票的平均 12 个月目标价格为 15.00 美元。</p>
<ul>
<li>医疗设备的未来：你不能错过的两个强烈买入</li>
</ul>
<p>此外，Roth Mkm 在周二的研究报告中重申了 “买入” 评级，并将 InfuSystem 的目标价格设定为 15.00 美元。</p>
<p><strong>阅读我们关于 INFU 的最新研究报告</strong></p>
<h2>机构投资者对 InfuSystem 的看法</h2>
<p>几家机构投资者最近增加或减少了在 INFU 的持股。Minerva Advisors LLC 在第四季度将其在 InfuSystem 的持股增加了 5.2%。Minerva Advisors LLC 目前拥有 1,078,731 股该公司股票，价值 9,676,000 美元，此前在上个季度又购买了 52,942 股。Vanguard Group Inc. 在第三季度将其在 InfuSystem 的持股增加了 1.9%。Vanguard Group Inc. 目前拥有 976,177 股该公司股票，价值 10,113,000 美元，此前在上个季度又购买了 18,539 股。Punch &amp; Associates Investment Management Inc. 在第四季度将其在 InfuSystem 的持股增加了 1.9%。Punch &amp; Associates Investment Management Inc. 目前拥有 824,750 股该公司股票，价值 7,398,000 美元，此前在上个季度又收购了 15,000 股。Renaissance Technologies LLC 在第四季度将其在 InfuSystem 的持股增加了 2.0%。Renaissance Technologies LLC 目前拥有 587,509 股该公司股票，价值 5,270,000 美元，此前在上个季度又购买了 11,795 股。最后，Dimensional Fund Advisors LP 在第三季度将其在 InfuSystem 的持股增加了 0.8%。Dimensional Fund Advisors LP 目前拥有 569,238 股该公司股票，价值 5,898,000 美元，此前在上个季度又购买了 4,430 股。对冲基金和其他机构投资者持有该公司 71.13% 的股份。</p>
<h2>InfuSystem 股票表现</h2>
<p>在周二的午盘交易中，INFU 股票上涨了 1.02 美元，达到 8.60 美元。该公司的交易量为 180,783 股，而其平均交易量为 138,861 股。该股票的 50 日移动平均价格为 8.45 美元，200 日移动平均价格为 9.33 美元。InfuSystem 的一年低点为 4.61 美元，一年高点为 11.04 美元。该公司的债务与股本比率为 0.50，流动比率为 1.98，速动比率为 1.59。该公司的市值为 1.7489 亿美元，市盈率为 143.36，贝塔值为 1.67。</p>
<h2>关于 InfuSystem</h2>
<p>(获取免费报告)</p>
<p>InfuSystem Holdings Inc 是一家医疗技术公司，专注于租赁、管理和服务主要用于门诊输液治疗的输液泵及相关设备。该公司提供一整套服务，包括设备交付、安装和回收、预防性和纠正性维护、再处理和质量保证。InfuSystem 的产品旨在帮助医院、门诊手术中心、肿瘤诊所和私人输液室简化临床操作，并保持符合安全标准。</p>
<p>除了泵的租赁和维修服务外，InfuSystem 还扩展到了远程患者监测解决方案。</p>
<h2>进一步阅读</h2>
<ul>
<li>五只我们更看好的股票，胜过 InfuSystem</li>
<li>这让我感到愤怒</li>
<li>埃隆·马斯克：这可能将 100 美元变成 100,000 美元</li>
<li>白银支付 20% 的股息。此外还有 68% 的股价上涨</li>
<li>揭示：白宫背后正在发生重大事件</li>
<li>今年哪些费用可以从资本利得税中扣除？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 InfuSystem 吗？</h2>
<p>在你考虑 InfuSystem 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 InfuSystem 并不在名单上。</p>
<p>虽然 InfuSystem 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

InfuSystems控股

<p>InfuSystem Holdings, Inc.（纽约证券交易所代码：INFU）获得了五位分析师的平均 “买入” 推荐。该股票的 12 个月目标价为 15.00 美元。最近的机构投资包括 Minerva Advisors 将其持股增加 5.2%，以及 Vanguard Group 将其持股增加 1.9%。INFU 股票交易价格为 8.60 美元，市值为 1.7489 亿美元。该公司专注于门诊治疗的输液泵租赁和管理，并已扩展到远程患者监测解决方案</p>

<p>InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) has been given an average recommendation of &#34;Buy&#34; by the five analysts that are covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, two have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $15.00.</p>
<div class="lb-trans"><p>InfuSystem Holdings, Inc. (NYSE:INFU - 获取免费报告) 收到了五位分析师的平均推荐评级为 “买入”，MarketBeat 报道。一位投资分析师给予该股票持有评级，两位给予买入评级，另外两位则对该公司给予强烈买入评级。在过去一年中，发布报告的经纪人对该股票的平均 12 个月目标价格为 15.00 美元。</p>
</div><ul>
<li>The Future of Medical Devices: Two Strong Buys You Can't Miss</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗设备的未来：你不能错过的两个强烈买入</li>
</ul>
</div><p>Separately, Roth Mkm restated a &#34;buy&#34; rating and set a $15.00 price target on shares of InfuSystem in a research note on Tuesday.</p>
<div class="lb-trans"><p>此外，Roth Mkm 在周二的研究报告中重申了 “买入” 评级，并将 InfuSystem 的目标价格设定为 15.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on INFU</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 INFU 的最新研究报告</strong></p>
</div><h2>Institutional Investors Weigh In On InfuSystem</h2>
<div class="lb-trans"><h2>机构投资者对 InfuSystem 的看法</h2>
</div><p>Several institutional investors have recently added to or reduced their stakes in INFU. Minerva Advisors LLC increased its stake in InfuSystem by 5.2% during the 4th quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company's stock valued at $9,676,000 after purchasing an additional 52,942 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of InfuSystem by 1.9% during the third quarter. Vanguard Group Inc. now owns 976,177 shares of the company's stock valued at $10,113,000 after buying an additional 18,539 shares during the last quarter. Punch &amp; Associates Investment Management Inc. increased its position in shares of InfuSystem by 1.9% during the fourth quarter. Punch &amp; Associates Investment Management Inc. now owns 824,750 shares of the company's stock valued at $7,398,000 after acquiring an additional 15,000 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of InfuSystem by 2.0% in the fourth quarter. Renaissance Technologies LLC now owns 587,509 shares of the company's stock worth $5,270,000 after purchasing an additional 11,795 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its holdings in shares of InfuSystem by 0.8% during the third quarter. Dimensional Fund Advisors LP now owns 569,238 shares of the company's stock valued at $5,898,000 after purchasing an additional 4,430 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者最近增加或减少了在 INFU 的持股。Minerva Advisors LLC 在第四季度将其在 InfuSystem 的持股增加了 5.2%。Minerva Advisors LLC 目前拥有 1,078,731 股该公司股票，价值 9,676,000 美元，此前在上个季度又购买了 52,942 股。Vanguard Group Inc. 在第三季度将其在 InfuSystem 的持股增加了 1.9%。Vanguard Group Inc. 目前拥有 976,177 股该公司股票，价值 10,113,000 美元，此前在上个季度又购买了 18,539 股。Punch &amp; Associates Investment Management Inc. 在第四季度将其在 InfuSystem 的持股增加了 1.9%。Punch &amp; Associates Investment Management Inc. 目前拥有 824,750 股该公司股票，价值 7,398,000 美元，此前在上个季度又收购了 15,000 股。Renaissance Technologies LLC 在第四季度将其在 InfuSystem 的持股增加了 2.0%。Renaissance Technologies LLC 目前拥有 587,509 股该公司股票，价值 5,270,000 美元，此前在上个季度又购买了 11,795 股。最后，Dimensional Fund Advisors LP 在第三季度将其在 InfuSystem 的持股增加了 0.8%。Dimensional Fund Advisors LP 目前拥有 569,238 股该公司股票，价值 5,898,000 美元，此前在上个季度又购买了 4,430 股。对冲基金和其他机构投资者持有该公司 71.13% 的股份。</p>
</div><h2>InfuSystem Price Performance</h2>
<div class="lb-trans"><h2>InfuSystem 股票表现</h2>
</div><p>INFU stock traded up $1.02 during midday trading on Tuesday, reaching $8.60. The company had a trading volume of 180,783 shares, compared to its average volume of 138,861. The stock has a 50 day moving average price of $8.45 and a 200-day moving average price of $9.33. InfuSystem has a 1-year low of $4.61 and a 1-year high of $11.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59. The company has a market capitalization of $174.89 million, a price-to-earnings ratio of 143.36 and a beta of 1.67.</p>
<div class="lb-trans"><p>在周二的午盘交易中，INFU 股票上涨了 1.02 美元，达到 8.60 美元。该公司的交易量为 180,783 股，而其平均交易量为 138,861 股。该股票的 50 日移动平均价格为 8.45 美元，200 日移动平均价格为 9.33 美元。InfuSystem 的一年低点为 4.61 美元，一年高点为 11.04 美元。该公司的债务与股本比率为 0.50，流动比率为 1.98，速动比率为 1.59。该公司的市值为 1.7489 亿美元，市盈率为 143.36，贝塔值为 1.67。</p>
</div><h2>About InfuSystem</h2>
<div class="lb-trans"><h2>关于 InfuSystem</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.</p>
<div class="lb-trans"><p>InfuSystem Holdings Inc 是一家医疗技术公司，专注于租赁、管理和服务主要用于门诊输液治疗的输液泵及相关设备。该公司提供一整套服务，包括设备交付、安装和回收、预防性和纠正性维护、再处理和质量保证。InfuSystem 的产品旨在帮助医院、门诊手术中心、肿瘤诊所和私人输液室简化临床操作，并保持符合安全标准。</p>
</div><p>In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.</p>
<div class="lb-trans"><p>除了泵的租赁和维修服务外，InfuSystem 还扩展到了远程患者监测解决方案。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than InfuSystem</li>
<li>This makes me furious</li>
<li>Elon Musk: This Could Turn $100 into $100,000</li>
<li>Silver paying 20% dividend. Plus 68% share gains</li>
<li>REVEALED: Something Big Happening Behind White House Doors</li>
<li>What Expenses Can Be Deducted From Capital Gains Tax This Year?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 InfuSystem</li>
<li>这让我感到愤怒</li>
<li>埃隆·马斯克：这可能将 100 美元变成 100,000 美元</li>
<li>白银支付 20% 的股息。此外还有 68% 的股价上涨</li>
<li>揭示：白宫背后正在发生重大事件</li>
<li>今年哪些费用可以从资本利得税中扣除？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlORlU" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NYSE&amp;Symbol=INFU"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in InfuSystem Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 InfuSystem 吗？</h2>
</div><p>Before you consider InfuSystem, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 InfuSystem 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InfuSystem wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 InfuSystem 并不在名单上。</p>
</div><p>While InfuSystem currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 InfuSystem 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

InfuSystem 控股公司（NYSE: INFU）被券商给予平均 “买入” 评级